PAA 2.86% 17.0¢ pharmaust limited

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1228

  1. 2,802 Posts.
    lightbulb Created with Sketch. 2861
    long story short they have not reached a trial end point so they don’t report on individual cases. The fact they gave an update in the quarterly is above and beyond what other biotechs would have done.

    don’t see an issue here, Monepantel is not a cure it’s a treatment. The test is only whether it prolongs survival longer than current standard of care around 6-9 months.

    i am interested to see who steps into the ring as CEO in coming months.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.0¢
Change
-0.005(2.86%)
Mkt cap ! $85.12M
Open High Low Value Volume
18.0¢ 18.0¢ 17.0¢ $127.1K 720.7K

Buyers (Bids)

No. Vol. Price($)
11 537419 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 100189 6
View Market Depth
Last trade - 15.36pm 06/09/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.